Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 181

Related Citations for PubMed (Select 14960741)

1.

Use of B-type natriuretic peptide in the evaluation and management of acute dyspnea.

Mueller C, Scholer A, Laule-Kilian K, Martina B, Schindler C, Buser P, Pfisterer M, Perruchoud AP.

N Engl J Med. 2004 Feb 12;350(7):647-54.

2.

Use of B-type natriuretic peptide for the management of women with dyspnea.

Mueller C, Laule-Kilian K, Scholer A, Frana B, Rodriguez D, Schindler C, Marsch S, Perruchoud AP.

Am J Cardiol. 2004 Dec 15;94(12):1510-4.

PMID:
15589006
3.

Cost-effectiveness of B-type natriuretic peptide testing in patients with acute dyspnea.

Mueller C, Laule-Kilian K, Schindler C, Klima T, Frana B, Rodriguez D, Scholer A, Christ M, Perruchoud AP.

Arch Intern Med. 2006 May 22;166(10):1081-7.

PMID:
16717170
4.

N-terminal pro-brain natriuretic peptide testing in the emergency department: beneficial effects on hospitalization, costs, and outcome.

Rutten JH, Steyerberg EW, Boomsma F, van Saase JL, Deckers JW, Hoogsteden HC, Lindemans J, van den Meiracker AH.

Am Heart J. 2008 Jul;156(1):71-7. doi: 10.1016/j.ahj.2008.02.021. Epub 2008 May 27.

PMID:
18585499
5.

The use of B-type natriuretic peptide in the management of elderly patients with acute dyspnoea.

Mueller C, Laule-Kilian K, Frana B, Rodriguez D, Rudez J, Scholer A, Buser P, Pfisterer M, Perruchoud AP.

J Intern Med. 2005 Jul;258(1):77-85.

PMID:
15953135
6.

Use of B-type natriuretic peptide in the management of acute dyspnea in patients with pulmonary disease.

Mueller C, Laule-Kilian K, Frana B, Rodriguez D, Scholer A, Schindler C, Perruchoud AP.

Am Heart J. 2006 Feb;151(2):471-7.

PMID:
16442916
7.

B-type natriuretic peptide for acute dyspnea in patients with kidney disease: insights from a randomized comparison.

Mueller C, Laule-Kilian K, Scholer A, Nusbaumer C, Zeller T, Staub D, Perruchoud AP.

Kidney Int. 2005 Jan;67(1):278-84.

PMID:
15610252
8.

B-type natriuretic peptide testing, clinical outcomes, and health services use in emergency department patients with dyspnea: a randomized trial.

Schneider HG, Lam L, Lokuge A, Krum H, Naughton MT, De Villiers Smit P, Bystrzycki A, Eccleston D, Federman J, Flannery G, Cameron P.

Ann Intern Med. 2009 Mar 17;150(6):365-71.

PMID:
19293069
9.

Medical and economic long-term effects of B-type natriuretic peptide testing in patients with acute dyspnea.

Breidthardt T, Laule K, Strohmeyer AH, Schindler C, Meier S, Fischer M, Scholer A, Noveanu M, Christ M, Perruchoud AP, Mueller C.

Clin Chem. 2007 Aug;53(8):1415-22. Epub 2007 Jun 22.

10.

Rapid measurement of B-type natriuretic peptide in the emergency diagnosis of heart failure.

Maisel AS, Krishnaswamy P, Nowak RM, McCord J, Hollander JE, Duc P, Omland T, Storrow AB, Abraham WT, Wu AH, Clopton P, Steg PG, Westheim A, Knudsen CW, Perez A, Kazanegra R, Herrmann HC, McCullough PA; Breathing Not Properly Multinational Study Investigators.

N Engl J Med. 2002 Jul 18;347(3):161-7.

11.

Meta-analysis: effect of B-type natriuretic peptide testing on clinical outcomes in patients with acute dyspnea in the emergency setting.

Lam LL, Cameron PA, Schneider HG, Abramson MJ, Müller C, Krum H.

Ann Intern Med. 2010 Dec 7;153(11):728-35. doi: 10.7326/0003-4819-153-11-201012070-00006.

PMID:
21135296
12.

Natriuretic peptide testing in EDs for managing acute dyspnea: a meta-analysis.

Trinquart L, Ray P, Riou B, Teixeira A.

Am J Emerg Med. 2011 Sep;29(7):757-67. doi: 10.1016/j.ajem.2010.02.026. Epub 2010 May 1.

PMID:
20825895
13.

Impact of the history of congestive heart failure on the utility of B-type natriuretic peptide in the emergency diagnosis of heart failure: results from the Breathing Not Properly Multinational Study.

Strunk A, Bhalla V, Clopton P, Nowak RM, McCord J, Hollander JE, Duc P, Storrow AB, Abraham WT, Wu AH, Steg G, Perez A, Kazanegra R, Herrmann HC, Aumont MC, McCullough PA, Maisel A.

Am J Med. 2006 Jan;119(1):69.e1-11.

PMID:
16431187
14.

Diagnostic and prognostic value of uric acid in patients with acute dyspnea.

Reichlin T, Potocki M, Breidthardt T, Noveanu M, Hartwiger S, Burri E, Klima T, Stelzig C, Laule K, Mebazaa A, Christ M, Mueller C.

Am J Med. 2009 Nov;122(11):1054.e7-1054.e14. doi: 10.1016/j.amjmed.2009.04.023.

PMID:
19854335
15.

Diagnostic performance and cost effectiveness of measurements of plasma N-terminal pro brain natriuretic peptide in patients presenting with acute dyspnea or peripheral edema.

Behnes M, Brueckmann M, Ahmad-Nejad P, Lang S, Wolpert C, Elmas E, Kaelsch T, Gruettner J, Weiss C, Borggrefe M, Neumaier M.

Int J Cardiol. 2009 Jun 26;135(2):165-74. doi: 10.1016/j.ijcard.2008.03.045. Epub 2008 Jul 7.

PMID:
18603317
16.

Primary results of the Rapid Emergency Department Heart Failure Outpatient Trial (REDHOT). A multicenter study of B-type natriuretic peptide levels, emergency department decision making, and outcomes in patients presenting with shortness of breath.

Maisel A, Hollander JE, Guss D, McCullough P, Nowak R, Green G, Saltzberg M, Ellison SR, Bhalla MA, Bhalla V, Clopton P, Jesse R; Rapid Emergency Department Heart Failure Outpatient Trial investigators.

J Am Coll Cardiol. 2004 Sep 15;44(6):1328-33.

PMID:
15364340
18.

Short-term mortality risk in emergency department acute heart failure.

Peacock WF, Nowak R, Christenson R, DiSomma S, Neath SX, Hartmann O, Mueller C, Ponikowski P, Möckel M, Hogan C, Wu AH, Richards M, Filippatos GS, Anand I, Ng LL, Daniels LB, Morgenthaler N, Anker SD, Maisel AS.

Acad Emerg Med. 2011 Sep;18(9):947-58. doi: 10.1111/j.1553-2712.2011.01150.x.

PMID:
21906204
20.

Influence of history of heart failure on diagnostic performance and utility of B-type natriuretic peptide testing for acute dyspnea in the emergency department.

Chung T, Sindone A, Foo F, Dwyer A, Paoloni R, Janu MR, Wong H, Hall J, Freedman SB.

Am Heart J. 2006 Nov;152(5):949-55.

PMID:
17070166
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk